Significantly rebounded. It has been announced that a commemorative dividend of ¥25.00 (no dividends in the same period last year) will be implemented at the end of the second quarter of the 25th fiscal year since establishment. This is the first dividend since establishment. The expected end-of-period dividend is zero, and the annual dividend will be ¥25.00. The expected operating profit for the 25th fiscal period ending in March is ¥600 million, an increase of 45.0% compared to the previous period. In the main business of cell bank business, marketing is promoted in both digital and real aspects. Operating profit for the fiscal year ended March 24 was ¥413 million, an increase of 39.1% and a record high.
ステムセル研究所---大幅に反発、25年3月期第2四半期末配当予想は初配の25円、通期営業利益予想は45.0％増
Stemcell Laboratory----Significant rebound; dividend forecast for the 2nd quarter end of the fiscal year ending 25/3 was initially 25 yen, full year operating profit forecast increased 45.0%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.